ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ·Healthcare·Biotechnology
$9.60
-5.79%
Mkt Cap $1.05B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 23, 2026 | — | — | — | -$0.34 | -$0.30 | +11.76% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.41 | -$0.33 | +19.51% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.46 | -$0.47 | -2.17% | — | — |
| Q2 2025 May 5, 2025 | — | — | — | -$0.51 | -$0.42 | +17.65% | — | — |
| Q1 2025 Feb 18, 2025 | — | $533.00K | — | -$0.52 | -$0.51 | +1.92% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.48 | -$0.49 | -2.08% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.42 | -$0.45 | -7.14% | — | — |
| Q2 2024 May 6, 2024 | — | — | — | -$0.44 | -$0.37 | +15.91% | — | — |
| Q1 2024 Mar 11, 2024 | — | $1.54M | — | -$0.49 | -$0.49 | +0.00% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$0.46 | -$0.44 | +4.35% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.58 | -$0.50 | +13.79% | — | — |
| Q2 2023 May 8, 2023 | — | — | — | -$0.54 | -$0.53 | +1.85% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.56 | -$0.52 | +7.14% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.55 | -$0.63 | -14.55% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.60 | -$0.51 | +15.00% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.57 | -$0.59 | -3.51% | — | — |
| Q1 2022 Mar 21, 2022 | — | — | — | -$0.61 | -$0.58 | +4.92% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.58 | -$0.47 | +18.97% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.50 | -$0.57 | -14.00% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.48 | -$0.45 | +6.25% | — | — |